| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | AA | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Category | Name of initiative | Location | Brief description | Still active? | Contact details | |||||||||||||||||||||
2 | Hub | Cambridge Biomedical Campus | Cambridge, U.K. | The Cambridge Biomedical Campus combines world-class biomedical research, patient care and education on a single site. Now undergoing a major expansion that includes the co-location of companies alongside the existing 12,000-strong community of healthcare professionals and research scientists, the Campus is on track to becoming one of the leading biomedical centres in the world by 2020. | Y | http://cambridge-biomedical.com/ | |||||||||||||||||||||
3 | Hub | HealthHUB | Tampere, Finland | The HealthHUB brings together companies and operators that are oriented towards health, wellness, health technology and research. In addition to companies, it also brings clinicians, researchers, developers, consumers and end users around the same desk to refine ideas together. Many of the operators are already nearby; the HealthHUB is located on the Kauppi Medical Campus, which is a growing centre for medical research and healthcare, health technology and wellness. | Y | https://www.healthhub.fi/ | |||||||||||||||||||||
4 | Hub | Citylabs 1.0 | Manchester, U.K. | Citylabs 1.0 is a biomedical centre of excellence located on the Central Manchester University Hospitals NHS Foundation Trust (CMFT) campus, in the heart of Manchester’s Innovation District and within the largest clinical academic campus in Europe. One of the only developments of its kind in the UK, representing a stronger relationship between the NHS, academic health science communities and industry, and is strategically aligned with the NHS ‘Innovation, Health and Wealth’ agenda. This unique partnership offers companies based at Citylabs direct access to specialist clinical resources and expertise from researchers, clinicians and procurement teams based within the hospitals to support business growth. | Y | http://mspl.co.uk/campuses/citylabs-10/ | |||||||||||||||||||||
5 | Hub | Edinburgh Bioquarter | Edinburgh, U.K. | Co-location of academic research and clinical research facilities provides an opportunity for companies to engage with world-leading medical researchers and clinicians to progress new concepts from discovery, all the way through clinical trials, to establishing a commercially viable route to market.
There are currently nearly 900 hospital beds and 1,200 researchers here. By 2017, we expect these numbers to rise to more than 1,500 hospital beds and 2,000 researchers. | Y | http://www.edinburghbioquarter.com/about-us/ | |||||||||||||||||||||
6 | Hub | Imnperial White City Campus | London, U.K. | Imperial’s White City Campus will provide state-of-the-art space for translating research ideas into direct applications and spin-out companies. Plans for the site include a publicly accessible square, accommodation, leisure and retail facilities, a conference centre, and homes.
The Molecular Sciences Research Hub, due for completion by 2017 will be a 26,000m2 state-of-the-art science building housing research from Imperial’s Department of Chemistry to seed a new molecular sciences neighbourhood, connecting with work in synthetic biology, data sciences, digital and health. Connected to and sharing services with the Molecular Sciences Research Hub is the Translation and Innovation Hub -a dynamic, enterprising environment that will enable the translation of research outcomes into internationally significant technologies. The 23,000m2 building is scheduled to open in summer 2016. The Michael Uren Biomedical Engineering Research Hub will provide a world-class space to draw engineers, scientists and clinicians together to pursue life-changing research into new and affordable medical technology. | Y | http://www.imperial.ac.uk/white-city-campus/about/ | |||||||||||||||||||||
7 | Hub | Leiden Bio Science Park | Leiden, Netherlands | Leiden Bio Science Park is the leading life sciences cluster in the Netherlands and ranks among the top five most successful science parks in Europe. It is fully dedicated to biomedical life sciences and offers opportunities for both established companies and start-ups to flourish. | Y | https://leidenbiosciencepark.nl/ | |||||||||||||||||||||
8 | Hub | BioWin | Wallonia, Belgium | Created in July 2006, BioWin is the reference player in the field of health biotechnology and medical technologies in Wallonia (a region located South Brussels, in Belgium). The cluster federates all the Walloon stakeholders (companies, research centers and universities) involved in innovative R&D projects and/or trainings for the development of new products and services:
130 companies (which 5 global leaders: Baxter, Eurogentec-Kaneka, GSK, IBA and UCB). 400 research units (gathering more than 11.000 researchers). 5 universities (Université Catholique de Louvain - UCL, Université Libre de Bruxelles - ULB, Université de Liège - ULg, Université de Mons - UMons and Université de Namur - Namur). Several prestigious research institutes such as the Duve Institute, the Ludwig Institute for Cancer Research, the GIGA, IMI, CCMI, ICP, etc. | Y | http://www.biowin.org/biowin/en/5408-home.html | |||||||||||||||||||||
9 | Patient Innovation | Online | An open platform for patients and caregivers of any disease and geography to share solutions they developed to help them cope with the challenges imposed by their disease or health condition. | Y | https://patient-innovation.com/ | ||||||||||||||||||||||
10 | Tres Cantos Open Lab Foundation | Spain | The Tres Cantos Open Lab Foundation (TCOLF), created in 2010, allows independent researchers to access GSK facilities, resources and expertise to help them advance their own research into diseases of the developing world. The Foundation is overseen by a Governing Board of leading scientists and provides funding and support to researchers to help them develop and advance ideas that could lead to new medicines to treat diseases of the developing world. Researchers supported by the Foundation are encouraged to share their work to ensure their discoveries are also available to other researchers. With over 50 projects in the portfolio, TCOLF activities are starting to bear fruit in terms of publications, validation of novel therapeutic modalities, promising lead optimisation programs and leveraged funding from third party agencies. Tres Cantos is supported by GSK. | Y | http://www.openlabfoundation.org/about.html | ||||||||||||||||||||||
11 | Stevenage Bioscience Catalyst | Stevenage, U.K. | Stevenage Bioscience Catalyst is a joint venture between the Department for Business Innovation and Skills, GlaxoSmithKline, the Wellcome Trust and Innovate UK. Our aim is to give the next generation of pharma and biotech companies access to a spectrum of translational research and development activities and opportunities. This culture of open innovation will accelerate the discovery of cutting-edge healthcare solutions and place the UK bioscience sector at the forefront of worldwide biomedical innovation. Stevenage Bioscience Catalyst offers access to equipment and facilities that would otherwise be beyond the reach of small or medium-sized companies. Our campus has been designed to foster cooperation, scientific and commercial dialogue and interaction between entrepreneurs in the Incubator and scientists on the GSK R&D site, while respecting their freedom to interact with any commercial or academic partners. | Y | http://www.stevenagecatalyst.com/ | ||||||||||||||||||||||
12 | Innovative Medicines Initiative | Europe | The Innovative Medicines Initiative (IMI) is working to improve health by speeding up the development of, and patient access to, innovative medicines, particularly in areas where there is an unmet medical or social need. It does this by facilitating collaboration between the key players involved in healthcare research, including universities, the pharmaceutical and other industries, small and medium-sized enterprises (SMEs), patient organisations, and medicines regulators. IMI is a partnership between the European Union (represented by the European Commission) and the European pharmaceutical industry (represented by EFPIA, the European Federation of Pharmaceutical Industries and Associations).
| Y | https://www.imi.europa.eu/content/home | ||||||||||||||||||||||
13 | Edison National Medical | U.S.A | Edison Nation Medical is a healthcare innovation marketplace with deep expertise in open innovation, product development, and healthcare. Born out of collaboration with Carolinas HealthCare System (one of the largest public health systems in the United States), Edison Nation Medical’s mission is to create more effective, more efficient and safer healthcare through open innovation. We make this a reality by providing a clear and easy pathway through which anyone — physicians, nurses, entrepreneurs, even patients and caregivers — can submit a healthcare invention idea for full evaluation and potential commercialization and by helping inventors to break through the traditional barriers of healthcare innovation. We accept ideas ranging from acute care to durable medical equipment (DME) to consumer healthcare products sold through retail.
Joining Edison Nation Medical is free and ideas submitted to our confidential and secure online portal are vetted through an in-depth review process led by our team of medical, product development and legal experts. Our end goal is to commercialize each qualified product idea and, when we are successful, we share licensing royalties with the inventor and celebrate together. | Y | http://edisonnationmedical.com/? | ||||||||||||||||||||||
14 | Prizes | Fighting Ebola grand challenge | US/Africa | "The Fighting Ebola Grand Challenge for Development is supporting 14 innovations identified for their potential to reinforce the response to current and future Ebola outbreaks. Selected from a pool of over 1,500 ideas through a rapid, rigorous review by U.S. Government experts and international partners, these ideas address a broad range of gaps in our near-term and long-term global response capacity. The first group of award nominees, announced in December 2014, focused on increasing the protection and comfort of health care workers battling Ebola. Building off this initial set, the second wave, announced in February 2015, includes innovations from improved health care worker tools, to rapidly deployable care settings and fresh community education approaches critical for the final stages of the outbreak response, and cutting-edge health information technology solutions that enhance the current response and provide a bridge toward longer-term recovery. Together, these innovations will work to strengthen Ebola-affected communities and health care systems, establishing a foundation for resilience." | Y | http://www.ebolagrandchallenge.net/ | |||||||||||||||||||||
15 | Health Innovation Hub | New Zealand | The New Zealand Health Innovation Hub is a partnership between four of the biggest District Health Boards: Auckland, Canterbury, Counties Manukau and Waitemata. We are also supported by the Ministry of Business, Innovation and Employment. We work alongside DHB innovators to develop new products and services that have commercial potential; are based on intellectual property; and improve health outcomes. We provide access to current information about the health landscape, market validation, potential investors and partners. | Y | http://innovation.health.nz/ | ||||||||||||||||||||||
16 | MedCity | UK | A collaboration between the Mayor of London and the capital’s three Academic Health Science Centres - Imperial College Academic Health Science Centre, King’s Health Partners, and UCL Partners launched to promote life sciences investment, entrepreneurship and industry in England’s greater south east. | Y | http://www.medcityhq.com/ | ||||||||||||||||||||||
17 | Co-creation | Hack It Up | UK | A crowdsourcing programme from the Cystic Fibrosis Trust that enables people with CF to communicate and contribute insights and ideas to developing treatments. Run by 100%Open, this is also open to medical professionals and carers. | https://hackitup.crowdicity.com/ | ||||||||||||||||||||||
18 | StartupBootCamp Digital Health | USA | London-based Startupbootcamp won a $2 million grant from the Knight Foundation to invest in, and help grow, thirty startups over three years in the Miama-Dade region. This is the first accelerator to focus on the eradication of healthcare disparities in the US. Ten startups innovating in healthcare are being selected to participate in the first three-month program. Included are an initial investment of $20,000 and the possibility of up to $100,000 in additional funding and $500,000 in in-kind services from partners such as Google, PayPal, and Amazon Web Services. Participating startups also receive free co-working office space for six months, one-on-one mentoring with healthcare investors and entrepreneurs, and educational opportunities such as hackathons, pitch days, and community events, with a focus on outreach efforts in underrepresented communities. In return, SBC is asking for a 6% equity stake. Applications close 17th June 2016 | Y | https://www.f6s.com/startupbootcampdigitalhealthmiami2016/about | ||||||||||||||||||||||
19 | Target Simplicity Challenge | USA | A nationwide search for innovative ideas to simplify healthcare in America. The Target Simplicity Challenge sought ideas in two categories, addressing some of the most critical opportunities in healthcare today: helping people make positive lifestyle and prevention choices, and helping people live well with a chronic condition. Submissions were judged by a panel of experts and thought leaders representing healthcare, retail, and technology. Winners received $25,000 and the opportunity to collaborate with Target on implementing the concept. | N | https://corporate.target.com/press/releases/2013/09/target-simplicity-challenge-seeks-innovative-ideas | ||||||||||||||||||||||
20 | Hubs | Alder Hey innovation hub | UK | Alder Hey Children's Hospital houses a new innovation hub with a focus on technology - part of the new Alder Hey 'Institute in the Park' which is being launched by Alder Hey and University of Liverpool | Y | http://www.alderhey.nhs.uk/alder-hey-building-a-healthier-future-for-children-everywhere/ | |||||||||||||||||||||
21 | Accelerators | NHS Innovation Accelerator | UK | Aimed at innovations that are ready to scale, but where there is no obvious route for adoption, accelerator aims to support innovators overcome systemic challenges to get uptake of innovations. Launched 2015 with 17 Fellows taking part. 12-month programme - participating 'Fellows' receive bursary of up to £30k plus access to mentoring, pairing with an AHSN, and access to peer support and wider networks. Programme has a core NIA team and is championed by all the AHSNs (Academic Health Science Networks). Applicants need to have resources to potentially scale within 12 months, so programme isn't really for startups - but is open to universities, industry, community sector and NHS. Second cohort being recruited in 2016. | Y | https://www.england.nhs.uk/ourwork/innovation/nia/ | |||||||||||||||||||||
22 | Accelerators | HBS-HMS Health Acceleration Challenge | Health care innovation scale up accelerator. From the website: "Some of the greatest health care innovations have taken decades to reach widespread adoption, adding to the ever-increasing cost of health care. We want to hear about solutions that have already been implemented at least once and have demonstrated effectiveness . This "scale-up" competition seeks to shorten the time frame for innovation dissemination. What's your innovation?" | Y | https://openforum.hbs.org/challenge/hbs-hms-health-acceleration-challenge/announce-winner | ||||||||||||||||||||||
23 | Co-creation | ATuServicio.uy | Uruguay | Every year in february around half the population in Uruguay has the option to change it’s health service provider. For several years key performance indicators have been published in spreadsheets but very few people actually consulted them. To promote informed decision making, DATA Uruguay worked with the Ministry of Health in the creation of a visualization and comparison tool that after it's second year has not only grown access over 13.000% but has also impacted on decreading prices of health services by making them easily accesible and comparable. | Y | http://atuservicio.uy | |||||||||||||||||||||
24 | Co-creation (starting an Accelerator programme) | HELIX | UK (London at St. Mary's Hospital in Paddington) | HELIX is short for Healthcare Innovation Exchange. It’s an exploration into how design can transform health when it’s placed on the front line of the medical world – an acute general hospital in Europe’s busiest city. A team of designers share a work space in a hospital with clinical practitioners and researchers. Together, they respond quickly to complex healthcare issues, turning ideas into prototype products, processes and services. HELIX is co-founded by Imperial College London and the Royal College of Art. Our philosophy is simple: real medical breakthroughs occur when people-centred design and scientific rigour collide. | Y | Email: hello@helixcentre.com | |||||||||||||||||||||
25 | Co-creation | The Mayo Clinic Center for Innovation | U.S.A. | The Mayo Clinic Center for Innovation fuses design principles with the scientific method to uncover human needs in the health care environment, which include empathy, creativity, systems thinking and a human-centered focus. Design methods include ethnographic and observational techniques, visualization, prototyping, sketching, storytelling, brainstorming and more. The complement of design allows the center to think beyond what it normally does and serve as a translator for ideas and possibilities. The center employs a diverse research team to design solutions that creatively address patients’ needs. | Y | http://centerforinnovation.mayo.edu/ | |||||||||||||||||||||
26 | Open innovation | OpenIDEO | U.S.A. | OpenIDEO is an open innovation platform and global community working together to design solutions for the world's biggest challenges. They host health-related challenges (and, those requiring a health lens). Example: https://challenges.openideo.com/challenge/end-of-life/refinement | Y | http://openideo.com/ | |||||||||||||||||||||
27 | Co-creation, open source | InSTEDD | U.S.A., Latin America, Southeast Asia | At InSTEDD we envision a world where communities everywhere design and use technology to continuously improve their health, safety and development. Founded in 2006 from the TED Prize, and based in California’s Silicon Valley, InSTEDD now operates around the world to implement our vision. Our work is often focused on addressing life-threatening gaps in communication and knowledge sharing. InSTEDD designs and uses open source technology tools to help partners improve collaboration, information flow and knowledge sharing to better deliver critical services to vulnerable populations. With long term sustainability in mind, our interdisciplinary team of public health experts, scientists, and software engineers help build local capacity to solve critical health, safety and sustainable development problems. Read more: http://instedd.org/about-us/ | Y | http://instedd.org/ | |||||||||||||||||||||
28 | Crowdsourcing | Ushahidi | Africa | Ushahidi, which translates to “testimony” in Swahili, was developed to map reports of violence in Kenya after the post-election violence in 2008. Since then, thousands have used our crowdsourcing tools to raise their voice. We’re a technology leader in Africa, headquartered in Nairobi, with a global team. | Y | https://www.ushahidi.com/about | |||||||||||||||||||||
29 | Co-creation; open source | Medic Mobile | U.S.A. | Medic Mobile is a nonprofit technology company specializing in mHealth. Health workers use Medic Mobile to register every pregnancy, track disease outbreaks faster, keep stock of essential medicines and communicate about emergencies. Their software toolkit combines smart messaging, decision support, easy data gathering and management, and health system analytics. The tools are free, open-source, and designed alongside people delivering care in the hardest-to-reach communities. Medic Mobile is used in over 20 countries with 39 partners. Over 9,000 health workers currently use Medic Mobile. | Y | http://medicmobile.org/ | |||||||||||||||||||||
30 | Platform; Co-creation | Colab | Brazil | ||||||||||||||||||||||||
31 | Co-creation, open source | OpenEyes | UK (Moorfields Eye Hospital, London) | OpenEyes is an electronic medical record for eye care - set up as a collaborative open source project with contributions from a range of hospitals, academic departments, institutions, companies and individuals. It allow clinicians to access data about their patients in one place. It is protected by a Foundation and the data cannot be sold to third parties. For providers, it gives a cost-effective solution for managing data (no licence fees). | Y | http://www.openeyes.org.uk/ | Not so much a model for promoting OI as an example of an innovation developed collaboratively? | ||||||||||||||||||||
32 | |||||||||||||||||||||||||||
33 | |||||||||||||||||||||||||||
34 | |||||||||||||||||||||||||||
35 | |||||||||||||||||||||||||||
36 | |||||||||||||||||||||||||||
37 | |||||||||||||||||||||||||||
38 | |||||||||||||||||||||||||||
39 | |||||||||||||||||||||||||||
40 | |||||||||||||||||||||||||||
41 | |||||||||||||||||||||||||||
42 | |||||||||||||||||||||||||||
43 | |||||||||||||||||||||||||||
44 | |||||||||||||||||||||||||||
45 | |||||||||||||||||||||||||||
46 | |||||||||||||||||||||||||||
47 | |||||||||||||||||||||||||||
48 | |||||||||||||||||||||||||||
49 | |||||||||||||||||||||||||||
50 | |||||||||||||||||||||||||||
51 | |||||||||||||||||||||||||||
52 | |||||||||||||||||||||||||||
53 | |||||||||||||||||||||||||||
54 | |||||||||||||||||||||||||||
55 | |||||||||||||||||||||||||||
56 | |||||||||||||||||||||||||||
57 | |||||||||||||||||||||||||||
58 | |||||||||||||||||||||||||||
59 | |||||||||||||||||||||||||||
60 | |||||||||||||||||||||||||||
61 | |||||||||||||||||||||||||||
62 | |||||||||||||||||||||||||||
63 | |||||||||||||||||||||||||||
64 | |||||||||||||||||||||||||||
65 | |||||||||||||||||||||||||||
66 | |||||||||||||||||||||||||||
67 | |||||||||||||||||||||||||||
68 | |||||||||||||||||||||||||||
69 | |||||||||||||||||||||||||||
70 | |||||||||||||||||||||||||||
71 | |||||||||||||||||||||||||||
72 | |||||||||||||||||||||||||||
73 | |||||||||||||||||||||||||||
74 | |||||||||||||||||||||||||||
75 | |||||||||||||||||||||||||||
76 | |||||||||||||||||||||||||||
77 | |||||||||||||||||||||||||||
78 | |||||||||||||||||||||||||||
79 | |||||||||||||||||||||||||||
80 | |||||||||||||||||||||||||||
81 | |||||||||||||||||||||||||||
82 | |||||||||||||||||||||||||||
83 | |||||||||||||||||||||||||||
84 | |||||||||||||||||||||||||||
85 | |||||||||||||||||||||||||||
86 | |||||||||||||||||||||||||||
87 | |||||||||||||||||||||||||||
88 | |||||||||||||||||||||||||||
89 | |||||||||||||||||||||||||||
90 | |||||||||||||||||||||||||||
91 | |||||||||||||||||||||||||||
92 | |||||||||||||||||||||||||||
93 | |||||||||||||||||||||||||||
94 | |||||||||||||||||||||||||||
95 | |||||||||||||||||||||||||||
96 | |||||||||||||||||||||||||||
97 | |||||||||||||||||||||||||||
98 | |||||||||||||||||||||||||||
99 | |||||||||||||||||||||||||||
100 |